ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 301457 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 301457; 2) Community: the network communities that were significantly associated with the response to NSC 301457; 3) Molecule: the relationships between components within communities and NSC 301457; 4) MDR: the compounds that were significantly associated with the NSC 301457.

NSC Compound Enrichment Correlation
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.0297837393005859 0.82527038
NSC 633207 Null 0.0297837393005859 0.49586068
NSC 638241 Null 0.0297837393005859 0.50794456
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0297837393005859 0.65924856
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.0297837393005859 0.64601424
NSC 641106 Benzenesulfonamide, N-[4-[[(4-carboxypheny)imino]methyl]- 3-methylphenyl]-N-(2-cyanoethyl)- 0.0297837393005859 0.77550362
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0297837393005859 0.68691971
NSC 664271 Null 0.0297837393005859 0.80764671
NSC 670784 Null 0.0297837393005859 0.33840262
NSC 674276 Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- 0.0297837393005859 -0.30710859
Total:96  Current:66    [First] [Prev] [Next] [Last]